DE69402241D1 - Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens - Google Patents
Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des RauchensInfo
- Publication number
- DE69402241D1 DE69402241D1 DE69402241T DE69402241T DE69402241D1 DE 69402241 D1 DE69402241 D1 DE 69402241D1 DE 69402241 T DE69402241 T DE 69402241T DE 69402241 T DE69402241 T DE 69402241T DE 69402241 D1 DE69402241 D1 DE 69402241D1
- Authority
- DE
- Germany
- Prior art keywords
- acetylpyridine
- drug
- manufacture
- suppress smoking
- smoking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/063,258 US5336680A (en) | 1993-05-18 | 1993-05-18 | Smoking suppressant and method of application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69402241D1 true DE69402241D1 (de) | 1997-04-30 |
DE69402241T2 DE69402241T2 (de) | 1997-07-24 |
Family
ID=22048022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69402241T Expired - Fee Related DE69402241T2 (de) | 1993-05-18 | 1994-05-16 | Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens |
Country Status (7)
Country | Link |
---|---|
US (1) | US5336680A (de) |
EP (1) | EP0625352B1 (de) |
CN (1) | CN1075373C (de) |
AU (1) | AU675514B2 (de) |
CA (1) | CA2123853C (de) |
DE (1) | DE69402241T2 (de) |
TW (1) | TW257675B (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9702796D0 (sv) * | 1997-07-25 | 1997-07-25 | Pharmacia & Upjohn Ab | A device at a pharmaceutical container or inhaler |
US20080230078A1 (en) * | 2007-03-19 | 2008-09-25 | Oby George Tolman | Method of smoking cessation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4255439A (en) * | 1979-07-13 | 1981-03-10 | Irving Cooper | Means and method for aiding individuals to stop smoking |
US4521427A (en) * | 1983-05-17 | 1985-06-04 | Nietupski Ronald S | Appetite suppressant and method of application thereof |
-
1993
- 1993-05-18 US US08/063,258 patent/US5336680A/en not_active Expired - Fee Related
-
1994
- 1994-05-05 AU AU61893/94A patent/AU675514B2/en not_active Ceased
- 1994-05-16 EP EP94303468A patent/EP0625352B1/de not_active Expired - Lifetime
- 1994-05-16 DE DE69402241T patent/DE69402241T2/de not_active Expired - Fee Related
- 1994-05-18 CN CN94105605A patent/CN1075373C/zh not_active Expired - Fee Related
- 1994-05-18 CA CA002123853A patent/CA2123853C/en not_active Expired - Fee Related
- 1994-07-02 TW TW083106040A patent/TW257675B/zh active
Also Published As
Publication number | Publication date |
---|---|
DE69402241T2 (de) | 1997-07-24 |
CA2123853C (en) | 2000-08-01 |
TW257675B (de) | 1995-09-21 |
CN1075373C (zh) | 2001-11-28 |
AU675514B2 (en) | 1997-02-06 |
CA2123853A1 (en) | 1994-11-19 |
US5336680A (en) | 1994-08-09 |
CN1105856A (zh) | 1995-08-02 |
EP0625352A1 (de) | 1994-11-23 |
EP0625352B1 (de) | 1997-03-26 |
AU6189394A (en) | 1994-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69306063D1 (de) | Verwendung von L-2-Oxothiazolidin-4-Carboxylatestern zur Herstellung eines Arzneimittels zur Stimulierung der intracellulären Glutathionsynthese | |
DE68928783D1 (de) | Zwischenverbindungen zur Herstellung von Fungiziden | |
DE69534002D1 (de) | Verwendung von Phosphatidylserinen zur Herstellung eines Arzneimittels zur Verbesserung der Gehirntätigkeit | |
ATA68386A (de) | Verwendung von 3'-azido-3'-desoxythymidin oder eines pharmazeutisch annehmbaren derivats hievon zur herstellung von medikamenten | |
ATE184602T1 (de) | Dialkoxypyridinylbenzimidazolderivate, verfahren zur herstellung und ihre pharmazeutische verwendung | |
DE69310065D1 (de) | Verwendung von 2-(3,4-Dimethoxycinnamoyl)aminobenzoesäure zur Herstellung eines Arzeimittels zur Behandlung der Restenose | |
ATE135577T1 (de) | Verwendung von buspiron zur herstellung eines pharmazeutischen präparats zur behandlung der alkoholsucht | |
DE69307962D1 (de) | Verfahren zur Herstellung von Filterzigaretten | |
DE69432158D1 (de) | Verfahren zur Herstellung von optisch aktiven 2-Amino-1-phenylethanol Derivaten | |
ATE137965T1 (de) | Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege | |
DE68924714D1 (de) | Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen. | |
DE69219428D1 (de) | Verfahren zur Herstellung von Mitteldestillaten | |
DE69221841D1 (de) | Verfahren zur Herstellung von gereinigtem Xanthangummi | |
DE69207696D1 (de) | Einschritt-Verfahren zur Herstellung von Dirithromycin | |
DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
DE69123025D1 (de) | Verfahren zur Herstellung von optisch aktiven Gamma-butyrolactonderivaten | |
DE69125489D1 (de) | Verwendung von derivaten durch menschliches gallensalz stimulierter lipase zur herstellung von medikamenten | |
DE3874229D1 (de) | Verwendung von dioxopiperidin-derivaten zur herstellung eines topischen praeparates als analgetika. | |
DE69116580D1 (de) | Direktes Verfahren zur Herstellung von aktivierten Antiperspirantsalzen | |
DE69005978D1 (de) | Verwendung von Actinonin zur Herstellung eines Medikamentes zur Inhibierung der Angiogenese. | |
DE69103865D1 (de) | Verwendung von tetrahydro-isoquinoline-derivate zur herstellung eines arzneimittels mit antitumoraler wirkung. | |
DE69406342D1 (de) | Verfahren zur Herstellung von Filterzigaretten | |
DE68905657D1 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
DE69402241D1 (de) | Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens | |
EE03090B1 (et) | Kinoliin-3-karboksamiidühendite kasutamine kompositsiooni valmistamiseks I tüüpi suhkurtõve raviks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |